Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction

W C Sternbergh1, M Sobel, R G Makhoul

  • 1Department of Surgery, Medical College of Virginia, Richmond.

Journal of Vascular Surgery
|March 1, 1995
PubMed
Summary

Heparinoids with low anticoagulant activity protect against ischemia-reperfusion injury by improving endothelial function, independent of their blood-thinning effects. This suggests a novel therapeutic mechanism beyond anticoagulation for endothelial cell protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision in Stroke Care: Novel Model for Predicting Functional Independence in Urgent Carotid Intervention Patients.

Journal of the American College of Surgeons·2025
Same author

Severe Increase in Nursing Labor Cost and Effect on Surgical Department Financial Margins at an Academic, Tertiary Medical Center.

Journal of the American College of Surgeons·2023
Same author

Providers' perspectives on the reproductive decision-making of BRCA-positive women.

BMC women's health·2022
Same author

Midtarsal break variation in modern humans: Functional causes, skeletal correlates, and paleontological implications.

American journal of physical anthropology·2015
Same author

Ultrasound findings after endovascular stent deployment in transplant liver hepatic artery stenosis.

AJR. American journal of roentgenology·2014
Same author

Laparoscopic versus robot-assisted surgery for median arcuate ligament syndrome.

Surgical endoscopy·2013

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Cardiovascular Research

Background:

  • Standard heparin mitigates endothelial cell dysfunction in ischemia-reperfusion injury.
  • The precise mechanism behind heparin's protective effects on endothelial cells is not fully understood.
  • Existing hypotheses suggest heparin's benefits may be independent of its anticoagulant properties.

Purpose of the Study:

  • To investigate whether heparin's protective effects on endothelial cells during ischemia-reperfusion injury are independent of its anticoagulant activity.
  • To determine if heparin's salutary endothelial effects are due to nonspecific polyanion interactions.
  • To explore novel therapeutic mechanisms for heparin in cardiovascular conditions.

Main Methods:

  • Isolated rat hindlimbs were subjected to normothermic ischemia followed by reperfusion.

Related Experiment Videos

  • Endothelial function was assessed by measuring acetylcholine-induced vasodilation (endothelial-dependent) and nitroprusside-induced vasodilation (endothelial-independent).
  • Animals were pretreated with heparinoids of varying anticoagulant activity, including dextran sulfate.
  • Main Results:

    • Heparinoids with low anticoagulant activity significantly improved endothelial-dependent vasodilation post-ischemia-reperfusion, comparable to non-ischemic controls.
    • Dextran sulfate, a similar polyanion, did not confer protection, indicating the effect is not due to nonspecific polyanion action.
    • Endothelial-independent vasodilation remained largely unaffected by the treatments.

    Conclusions:

    • A heparinoid with minimal antithrombin-binding activity (Astenose) effectively reduced post-ischemic endothelial dysfunction.
    • These findings strongly suggest that heparin's protective mechanism in this context is independent of its anticoagulant properties.
    • The study highlights a potential non-anticoagulant therapeutic role for heparin derivatives in managing endothelial dysfunction.